Literature DB >> 12717047

Substance abuse and HIV infection.

Henry Francis1.   

Abstract

Substance abuse facilitates the spread of HIV infection and complicates its management. Successful treatment of HIV disease and other comorbidities in substance abusers requires treatment of substance abuse. At the Clinical Pathway of the Ryan White CARE Act 2002 All Grantee Conference held in Washington, DC, in August 2002, Henry Francis, MD, discussed characteristics of substance abuse in the United States and obstacles and approaches to successful treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717047

Source DB:  PubMed          Journal:  Top HIV Med        ISSN: 1542-8826


  14 in total

1.  Substance abuse treatment as HIV prevention: more questions than answers.

Authors:  Lawrence S Brown; Steven Kritz; Edmund J Bini; Ben Louie; Jim Robinson; Donald Alderson; John Rotrosen
Journal:  J Natl Med Assoc       Date:  2010-12       Impact factor: 1.798

2.  Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs in the United States.

Authors:  Edmund J Bini; Steven Kritz; Lawrence S Brown; Jim Robinson; Don Alderson; John Rotrosen
Journal:  J Addict Dis       Date:  2011-04

3.  Provision of onsite HIV Services in Substance Use Disorder Treatment Programs: A Longitudinal Analysis.

Authors:  Lydia Aletraris; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2015-04-13

Review 4.  Pharmacogenomics of CYP3A: considerations for HIV treatment.

Authors:  Sukhwinder S Lakhman; Qing Ma; Gene D Morse
Journal:  Pharmacogenomics       Date:  2009-08       Impact factor: 2.533

5.  States and substance abuse treatment programs: funding and guidelines for infection-related services.

Authors:  Steven Kritz; Lawrence S Brown; R Jeffrey Goldsmith; Edmund J Bini; Jim Robinson; Donald Alderson; Patricia Novo; John Rotrosen
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

6.  Refining Current Scientific Priorities and Identifying New Scientific Gaps in HIV-Related Heart, Lung, Blood, and Sleep Research.

Authors:  Homer L Twigg; Ronald Crystal; Judith Currier; Paul Ridker; Nancy Berliner; Hans-Peter Kiem; George Rutherford; Shimian Zou; Simone Glynn; Renee Wong; Emmanuel Peprah; Michael Engelgau; Tony Creazzo; Sandra Colombini-Hatch; Elisabet Caler
Journal:  AIDS Res Hum Retroviruses       Date:  2017-06-26       Impact factor: 2.205

7.  Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: the National Drug Abuse Treatment Clinical Trials Network.

Authors:  Lawrence S Brown; Steven Allan Kritz; R Jeffrey Goldsmith; Edmund J Bini; John Rotrosen; Sherryl Baker; Jim Robinson; Patrick McAuliffe
Journal:  J Subst Abuse Treat       Date:  2006-06

8.  Ethnic differences in HIV risk behaviors among methadone-maintained women receiving contingency management for cocaine use disorders.

Authors:  Danielle Barry; Jeremiah Weinstock; Nancy M Petry
Journal:  Drug Alcohol Depend       Date:  2008-08-06       Impact factor: 4.492

9.  HIV-1 gp120 primes lymphocytes for opioid-induced, beta-arrestin 2-dependent apoptosis.

Authors:  Jonathan Moorman; Yi Zhang; Bindong Liu; Gene LeSage; Yangchao Chen; Charles Stuart; Deborah Prayther; Deling Yin
Journal:  Biochim Biophys Acta       Date:  2009-05-27

10.  Health services for HIV/AIDS, HCV, and sexually transmitted infections in substance abuse treatment programs.

Authors:  Lawrence S Brown; Steven Kritz; R Jeffrey Goldsmith; Edmund J Bini; Jim Robinson; Donald Alderson; John Rotrosen
Journal:  Public Health Rep       Date:  2007 Jul-Aug       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.